Bioage Labs Inc (BIOA) Hedge Fund & Institutional Holdings (Q2 2026)

BIOA ranks #3642 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

BIOA is a disclosed holding of Marc Andreessen (Andreessen Horowitz (a16z)), one of the tracked superinvestors on AlphaSMO — it makes up 0.6% of that fund's own 13F portfolio.

BIOA is a top-conviction position for Pivotal bioVenture Partners Investment Advisor LLC — at 5.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in BIOA belongs to a16z Capital Management, L.L.C., but the position matters far more to Pivotal bioVenture Partners Investment Advisor LLC, who has 5.2% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

BIOA is down 9.5% today, but institutions show net buying of $124.9M this quarter — a divergence between today's price move and the underlying institutional flow.

BIOA reported a net loss of $94.5M over the trailing twelve months.

• Not yet profitable — net loss of $94.5M over the trailing twelve months
• Revenue grew 168.1% year over year
• Net income declined year over year, from -$79.0M to -$94.5M
• Operating cash flow was negative, using $81.6M in cash
• Current ratio of 14.24x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.08x equity — within a conventional range